정형외과용 임플란트 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 소재별, 유통 채널별, 용도별, 지역별, 부문별 예측(2026-2033년)

Orthopedic Implants Market Summary

The global orthopedic implants market size was valued at USD 26.97 billion in 2025 and is projected to reach USD 36.63 billion by 2033, growing at a CAGR of 3.94% from 2026 to 2033. The market is driven by the growing prevalence of reduced bone density, weakened bones, and musculoskeletal disorders.

The surging risk of degenerative bone disorders is another factor driving market growth over the forecast period. In addition, the availability of advanced orthopedic implants and the rapid development of healthcare infrastructure globally are expected to positively impact market growth.

Global Orthopedic Implants Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For the purpose of this study, Grand View Research, Inc. has segmented the orthopedic implants market report on the basis of product, material, distribution channel, end use, and region.

• Product Outlook (Revenue, USD Million; Unit Volume in '000 Units; 2021 - 2033)
• Lower Extremity Implants
  • Knee Implants
  • Hip Implants
  • Foot & Ankle Implants
• Spinal Implants
• Dental
  • Dental Implants
  • Craniomaxillofacial Implants
• Upper Extremity Implants
  • Elbow Implants
  • Hand & Wrist Implants
  • Shoulder Implants
• Materials Outlook (Revenue, USD Million, 2021 - 2033)
• Metallic Material
  • Stainless steel
  • Titanium
  • Titanium Alloy
  • Cobalt Alloy
  • Others
• Ceramic Biomaterials
• Polymeric Biomaterials
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Offline
• Online
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million; Unit Volume in '000 Units; 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
• Rest of Latin America
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Rest of MEA

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Material outlook
  • 2.2.3. Distribution Channel outlook
  • 2.2.4. End Use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Orthopedic Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising demand for smart orthopedic implants
    • 3.2.1.2. Growing population aged 25 to 65 years and increasing burden of global geriatric population
    • 3.2.1.3. Increasing adoption of minimally invasive treatments
    • 3.2.1.4. Increasing number of sports injuries and road traffic accidents
    • 3.2.1.5. Increasing reimbursement coverage
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulatory framework
    • 3.2.2.2. Increasing number of product recalls
    • 3.2.2.3. Availability of alternative treatments
• 3.3. Orthopedic digit implants: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Orthopedic Implants Market: Product Pipeline Analysis
• 3.5. Orthopedic Disease Prevalence
• 3.6. Go-to-Market Strategy Analysis
• 3.7. Initiatives by key stakeholders in the Orthopedic Industry
• 3.8. Emergence of Smart Implants and Applications and Software In The Orthopedic Industry
• 3.9. Orthopedic Technology Trends for 2025
• 3.10. Regulatory Landscape and Compliance
• 3.11. Total Joint Replacement/ Orthopedic Implants Segment Sales Performance
• 3.12. Impact of COVID-19 Pandemic on Orthopedic Devices Market
• 3.13. Supply Chain Management in the Orthopedic Implants Market

Chapter 4. Orthopedic Implants Market Segment Analysis, By Product, Revenue in USD Million; Unit Volume in '000 Units, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Segment Dashboard
• 4.3. Global orthopedic implants market, By Product, 2021 to 2033
• 4.4. Lower Extremity Implants
  • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.4.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.4.3. Knee Implants
    • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.4.4. Hip Implants
    • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.4.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.4.5. Foot & Ankle Implants
    • 4.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.5.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
• 4.5. Spinal Implants
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
• 4.6. Upper Extremity Implants
  • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.6.3. Elbow Implants
    • 4.6.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.3.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.6.4. Hand & Wrist Implants
    • 4.6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.4.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.6.5. Shoulder Implants
    • 4.6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.5.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
• 4.7. Dental
  • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.7.3. Dental Implants
    • 4.7.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.3.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)
  • 4.7.4. Craniomaxillofacial Implants
    • 4.7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.4.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume in '000 Units)

Chapter 5. Orthopedic Implants Market Segment Analysis, By Material, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Segment Dashboard
• 5.3. Global orthopedic implants market, By Material, 2021 to 2033
• 5.4. Metallic Material
  • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.2. Stainless steel
    • 5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.3. Titanium
    • 5.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.4. Titanium Alloy
    • 5.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.5. Cobalt Alloy
    • 5.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.6. Others
    • 5.4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. Ceramic Biomaterials
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Polymeric Biomaterials
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Orthopedic Implants Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. Segment Dashboard
• 6.3. Global orthopedic implants market, By End Use, 2021 to 2033
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Outpatient Facilities
  • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Orthopedic Implants Market Segment Analysis, By Distribution Channel, 2021 - 2033 (USD Million)

• 7.1. Definition and Scope
• 7.2. Segment Dashboard
• 7.3. Global orthopedic implants market, by Distribution Channel, 2021 to 2033
• 7.4. Offline
  • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Online
  • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Orthopedic Implants Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Regional Market Snapshot
• 8.4. Orthopedic Implants Market Share by Region, 2025 & 2033:
• 8.5. North America
  • 8.5.1. North America orthopedic implants market, 2021 - 2033(USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. U.S. orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.5.2.5. U.S. orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Canada orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.5.3.5. Canada orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Mexico orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.5.4.5. Mexico orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
• 8.6. Europe
  • 8.6.1. Europe orthopedic implants market, 2021 - 2033 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. UK orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.2.5. UK orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.6.3. Germany
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Germany orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.3.5. Germany orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.6.4. France
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. France orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.4.5. France orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.6.5. Italy
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Italy orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.5.5. Italy orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.6.6. Spain
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. Spain orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.6.5. Spain orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.6.7. Norway
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Framework
    • 8.6.7.3. Competitive Scenario
    • 8.6.7.4. Norway orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.7.5. Norway orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.6.8. Sweden
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Regulatory Framework
    • 8.6.8.3. Competitive Scenario
    • 8.6.8.4. Sweden orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.8.5. Sweden orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.6.9. Denmark
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Regulatory Framework
    • 8.6.9.3. Competitive Scenario
    • 8.6.9.4. Denmark orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.6.9.5. Denmark orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key Country Dynamics
    • 8.7.1.2. Regulatory Framework
    • 8.7.1.3. Competitive Scenario
    • 8.7.1.4. Japan orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.7.1.5. Japan orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.7.2. China
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. China orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.7.2.5. China orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.7.3. India
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Framework
    • 8.7.3.3. Competitive Scenario
    • 8.7.3.4. India orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.7.3.5. India orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.7.4. Australia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Regulatory Framework
    • 8.7.4.3. Competitive Scenario
    • 8.7.4.4. Australia orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.7.4.5. Australia orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.7.5. South Korea
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Regulatory Framework
    • 8.7.5.3. Competitive Scenario
    • 8.7.5.4. South Korea orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.7.5.5. South Korea orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.7.6. Thailand
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Regulatory Framework
    • 8.7.6.3. Competitive Scenario
    • 8.7.6.4. Thailand orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.7.6.5. Thailand orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key Country Dynamics
    • 8.8.1.2. Regulatory Framework
    • 8.8.1.3. Competitive Scenario
    • 8.8.1.4. Brazil orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.8.1.5. Brazil orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.8.2. Argentina
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework
    • 8.8.2.3. Competitive Scenario
    • 8.8.2.4. Argentina orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.8.2.5. Argentina orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key Country Dynamics
    • 8.9.1.2. Regulatory Framework
    • 8.9.1.3. Competitive Scenario
    • 8.9.1.4. South Africa orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.9.1.5. South Africa orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key Country Dynamics
    • 8.9.2.2. Regulatory Framework
    • 8.9.2.3. Competitive Scenario
    • 8.9.2.4. Saudi Arabia orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.9.2.5. Saudi Arabia orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.9.3. UAE
    • 8.9.3.1. Key Country Dynamics
    • 8.9.3.2. Regulatory Framework
    • 8.9.3.3. Competitive Scenario
    • 8.9.3.4. UAE orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.9.3.5. UAE orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key Country Dynamics
    • 8.9.4.2. Regulatory Framework
    • 8.9.4.3. Competitive Scenario
    • 8.9.4.4. Kuwait orthopedic implants market, 2021 - 2033 (USD Million)
    • 8.9.4.5. Kuwait orthopedic implants market, 2021 - 2033 (Unit Volume in '000 Units)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Market Share Analysis, 2025
• 9.4. List of OEM in the Market
• 9.5. List of private players
• 9.6. List of top 10 key players in the market
• 9.7. Company Profiles
  • 9.7.1. Medtronic
    • 9.7.1.1. Company overview
    • 9.7.1.2. Financial performance
    • 9.7.1.3. Product benchmarking
    • 9.7.1.4. Strategic initiatives
  • 9.7.2. DePuy Synthes (Johnson & Johnson)
    • 9.7.2.1. Company overview
    • 9.7.2.2. Financial performance
    • 9.7.2.3. Product benchmarking
    • 9.7.2.4. Strategic initiatives
  • 9.7.3. Stryker Corporation
    • 9.7.3.1. Company overview
    • 9.7.3.2. Financial performance
    • 9.7.3.3. Product benchmarking
    • 9.7.3.4. Strategic initiatives
  • 9.7.4. Zimmer Biomet
    • 9.7.4.1. Company overview
    • 9.7.4.2. Financial performance
    • 9.7.4.3. Product benchmarking
    • 9.7.4.4. Strategic initiatives
  • 9.7.5. Smith+Nephew
    • 9.7.5.1. Company overview
    • 9.7.5.2. Financial performance
    • 9.7.5.3. Product benchmarking
    • 9.7.5.4. Strategic initiatives
  • 9.7.6. NuVasive, Inc. (mergerd with Globus Medical)
    • 9.7.6.1. Company overview
    • 9.7.6.2. Financial performance
    • 9.7.6.3. Product benchmarking
    • 9.7.6.4. Strategic initiatives
  • 9.7.7. Arthrex, Inc.
    • 9.7.7.1. Company overview
    • 9.7.7.2. Financial performance
    • 9.7.7.3. Product benchmarking
    • 9.7.7.4. Strategic initiatives
  • 9.7.8. Acumed, LLC
    • 9.7.8.1. Company overview
    • 9.7.8.2. Financial performance
    • 9.7.8.3. Product benchmarking
    • 9.7.8.4. Strategic initiatives
  • 9.7.9. Paragon Medical (AMETEK)
    • 9.7.9.1. Company overview
    • 9.7.9.2. Financial performance
    • 9.7.9.3. Product benchmarking
    • 9.7.9.4. Strategic initiatives
  • 9.7.10. Globus Medical
    • 9.7.10.1. Company overview
    • 9.7.10.2. Financial performance
    • 9.7.10.3. Product benchmarking
    • 9.7.10.4. Strategic initiatives